Hosted on MSN28d
Ahead of Gilead (GILD) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Wall Street analysts expect Gilead Sciences (GILD ... According to the collective judgment of analysts, 'Product Sales- AmBisome- U.S.' should come in at $7.44 million. The estimate indicates ...
Seeking Alpha3d
GILD Gilead Sciences, Inc.
Gilead Sciences, Inc., a biopharmaceutical company ... an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious ...